Catheter Precision (VTAK) Return on Equity (2018 - 2025)
Catheter Precision (VTAK) has disclosed Return on Equity for 8 consecutive years, with 2.41% as the latest value for Q4 2025.
- Quarterly Return on Equity fell 131.0% to 2.41% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.41% through Dec 2025, down 131.0% year-over-year, with the annual reading at 2.12% for FY2025, 130.0% down from the prior year.
- Return on Equity for Q4 2025 was 2.41% at Catheter Precision, down from 2.13% in the prior quarter.
- The five-year high for Return on Equity was 0.13% in Q3 2021, with the low at 6.66% in Q4 2023.
- Average Return on Equity over 5 years is 1.88%, with a median of 1.31% recorded in 2024.
- The sharpest move saw Return on Equity tumbled -488bps in 2023, then soared 570bps in 2024.
- Over 5 years, Return on Equity stood at 0.14% in 2021, then plummeted by -1619bps to 2.47% in 2022, then tumbled by -170bps to 6.66% in 2023, then soared by 84bps to 1.1% in 2024, then plummeted by -119bps to 2.41% in 2025.
- According to Business Quant data, Return on Equity over the past three periods came in at 2.41%, 2.13%, and 2.23% for Q4 2025, Q3 2025, and Q2 2025 respectively.